Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Morgan Stanley

These 3 Airline Stocks Have Analysts Feeling Bullish for 2025

Wall Street analysts are now bullish again on airline stocks, and investors can connect the dots on why that is through different data points.

Morgan Stanley Reportedly Considers Offering Crypto Trading Via E-Trade

Morgan Stanley Reportedly Considers Offering Crypto Trading Via E-Trade

Morgan Stanley is reportedly considering to add crypto trading to its E-Trade platform, and if does occur, the service could challenge the likes of Robinhood and even crypto-centric platforms such as Coinbase.

International Business Times

Here's What to Expect From Morgan Stanley's Next Earnings Report

Here's What to Expect From Morgan Stanley's Next Earnings Report

Analysts predict a double-digit profit boost for Morgan Stanley as it gears up to reveal its fourth-quarter earnings this month.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

As FX volume surges past $1 trillion a month, Morgan Stanley and BoA adopt a new system to charge for trades

As foreign exchange volumes explode nearly 30% in a year Morgan Stanley joined a wave of banks looking to modernize the way FX traders to business.

1 Quantum Computing Stock to Buy Hand Over Fist

As quantum computing is poised to thrive with AI breakthroughs and government backing, this stock’s immense potential makes it a must-have for investors now.

Is OKTA Stock a Buy, Sell, or Hold in 2025?

Amid Okta’s Q3 earnings rally, should investors double down for 2025 or play it cool and wait?

3 Companies Leading the Way With Aggressive Stock Buybacks

Stock buyback announcements are rolling out for a certain group of stocks to give investors new reasons to expect more upside potential.

inkl

Read news from The Economist, FT, and more,
with one subscription

GRAIL: Biotech Stock Targeting $100B Cancer Market

GRAIL: Biotech Stock Targeting $100B Cancer Market

GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market.

Stocks Pressured by Higher Bond Yields

Stocks Pressured by Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.41%. Stock indexes today are posting moderate losses, with the Dow Jones industrials falling to...

Stocks Weaken on Stagflation Concerns

Stocks Weaken on Stagflation Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.58%. Stock indexes today are mildly lower, with the Dow Jones industrials falling to a...

3 Top Stocks Set to Surge as Morgan Stanley Eyes Dollar Weakness

3 Top Stocks Set to Surge as Morgan Stanley Eyes Dollar Weakness

As Morgan Stanley analysts say to sell the dollar, a few stocks might outperform if their view is right. Domestic manufacturing and overseas stocks agree

Why Morgan Stanley Likes This Growth Stock for AI Upside in 2025

Why Morgan Stanley Likes This Growth Stock for AI Upside in 2025

With the launch of a new feature, analysts believes this company may soon join the S&P 500.

Stocks Settle Lower Ahead of US Inflation News

Stocks Settle Lower Ahead of US Inflation News

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.54%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.84%. Stocks on Monday settled lower, with the Dow Jones Industrials posting a 1-1/2 week...

Key Takeaways From BlackRock Analyst Ratings

Key Takeaways From BlackRock Analyst Ratings

Throughout the last three months, 15 analysts have evaluated BlackRock (NYSE:BLK), offering a diverse set of opinions from bullish to bearish.

Get all your
news in one place.

100's of premium titles.
One news app.

22 Analysts Assess Visa: What You Need To Know

Ratings for Visa (NYSE:V) were provided by 22 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Navigating 12 Analyst Ratings For Corpay

In the preceding three months, 12 analysts have released ratings for Corpay (NYSE:CPAY), presenting a wide array of perspectives from bullish to bearish.

Assessing T. Rowe Price Gr: Insights From 14 Financial Analysts

In the last three months, 14 analysts have published ratings on T. Rowe Price Gr (NASDAQ:TROW), offering a diverse range of perspectives from bullish to bearish.

Reddit Stock Gets Boost From Morgan Stanley: Analyst Sees 'Best In Class Growth'

Morgan Stanley upgrades Reddit stock to Overweight with $200 price target, citing potential for explosive growth and $300 bull case.

Get all your
news in one place.

100's of premium titles.
One news app.

Stocks Weaken Ahead of US Nov CPI Report

The S&P 500 Index ($SPX ) (SPY ) today is down -0.45%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.65%. Stocks today are under pressure, with the markets awaiting US inflation news this week...

Demystifying Lululemon Athletica: Insights From 20 Analyst Reviews

Providing a diverse range of perspectives from bullish to bearish, 20 analysts have published ratings on Lululemon Athletica (NASDAQ:LULU) in the last three months.

Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Critical Insights From Lazard Analyst Ratings: What You Need To Know

Ratings for Lazard (NYSE:LAZ) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts

In the last three months, 19 analysts have published ratings on Vertex Pharmaceuticals (NASDAQ:VRTX), offering a diverse range of perspectives from bullish to bearish.

Analyst Expectations For Moelis's Future

Moelis (NYSE:MC) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

1 … 22 23 24 25

People

179,253 stories

Matthew Harrison

Benjamin Budish

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

American Airlines

Bank of America

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

359,245 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play